James F. Young - Potomac MD, US Scott Koenig - Rockville MD, US Leslie S. Johnson - Germantown MD, US William D. Huse - Del Mar CA, US Jeffrey D. Watkins - Encinitas CA, US Herren Wu - Germantown MD, US
Assignee:
MedImmune, LLC - Gaithersburg MD
International Classification:
A61K 39/42 A61K 39/155
US Classification:
4241591, 4242111
Abstract:
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis of a RSV infection.
Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment
James F. Young - Potomac MD, US Scott Koenig - Rockville MD, US Leslie S. Johnson - Germantown MD, US William D. Huse - Del Mar CA, US Jeffrey D. Watkins - Encinitas CA, US Herren Wu - Boyds MD, US
Assignee:
MedImmune, LLC - Gaithersburg MD
International Classification:
C07H 21/04 A61K 39/42 A61K 39/155
US Classification:
536 2353, 4241591, 4242111
Abstract:
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis a RSV infection.
Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment
James Young - Potomac MD, US Scott Koenig - Rockville MD, US Leslie Johnson - Germantown MD, US William Huse - Del Mar CA, US Jeffrey Watkins - Encinitas CA, US Herren Wu - Boyds MD, US
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis a RSV infection
Methods Of Administering / Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment
JAMES F. YOUNG - POTOMAC MD, US SCOTT KOENIG - ROCKVILLE MD, US LESLIE S. JOHNSON - GERMANTOWN MD, US WILLIAM D. HUSE - DEL MAR CA, US JEFFREY D. WATKINS - ENCINITAS CA, US HERREN WU - BOYDS MD, US
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis a RSV infection
Medicine Doctors
Dr. Jeffrey R Watkins, Dallas TX - MD (Doctor of Medicine)
Dr. Watkins graduated from the Virginia Commonwealth University SOM in 1979. He works in Bemidji, MN and 1 other location and specializes in Cardiovascular Disease and Interventional Cardiology. Dr. Watkins is affiliated with Sanford Bemidji Medical Center.
Castle Orthopaedics/Sport MedicalCastle Orthopaedics & Sports Medicine SC 1315 N Highland Ave STE 103, Aurora, IL 60506 (630)8924286 (phone), (630)8920809 (fax)
Castle Orthopaedics/Sport MedicalCastle Orthopaedics & Sports Medicine SC 507 W Kendall Dr STE 4, Yorkville, IL 60560 (630)5533000 (phone), (630)8623086 (fax)
Castle Orthopaedics/Sport MedicalCastle Orthopaedics & Sports Medicine 2111 Ogden Ave, Aurora, IL 60504 (630)9783800 (phone), (630)8623086 (fax)
Procedures:
Arthrocentesis Hallux Valgus Repair
Conditions:
Plantar Fascitis Hallux Valgus Tinea Pedis
Languages:
English Spanish
Description:
Dr. Watkins works in Aurora, IL and 2 other locations and specializes in Podiatric Medicine. Dr. Watkins is affiliated with Presence Mercy Medical Center and Rush Copley Medical Center.
Methodist Dallas Medical Center General Surgery Residency 1441 N Beckley Ave, Dallas, TX 75203 (214)9472315 (phone)
Education:
Medical School University of Texas Southwestern Medical Center at Dallas Graduated: 2011
Languages:
English
Description:
Dr. Watkins graduated from the University of Texas Southwestern Medical Center at Dallas in 2011. He works in Dallas, TX and specializes in General Surgery.
Computers pay the bills, but my passion is songwriting and playing music. Check out my websites and listen to my music. I have a CD on iTunes. The goal is to get my songs published. The band name is &...